A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva

By Nakamura Takao   Ohbayashi Masahara   Toda Masako   Hall David   Horgan Carmel   Ono Santa  

Immunologic Research, Vol. 33, Iss. 3, 2005-12 ,pp. : 213-221

Humana Press, Inc

Access to resources Recommend Favorite

The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis

By Tokuyama Hirotake  

International Immunology, Vol. 17, Iss. 8, 2005-08 ,pp. : 1023-1034

Oxford University Press

Access to resources Recommend Favorite

Desensitization of Chemokine Receptor CCR5 in Dendritic Cells at the Early Stage of Differentiation by Activation of Formyl Peptide Receptors

By Le Y.   Wetzel M.A.   Shen W.   Gong W.   Rogers T.J.   Henderson E.E.   Wang J.M.  

Clinical Immunology, Vol. 99, Iss. 3, 2001-06 ,pp. : 365-372

Academic Press

Access to resources Recommend Favorite

A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation

By Boehme Stefen A.   Franz-Bacon Karin   Chen Edward P.   ik Roman   Sprague L. James   Ly Tai Wei   Hardiman Gary   Bacon Kevin B.  

International Immunology, Vol. 21, Iss. 1, 2009-01 ,pp. : 81-93

Oxford University Press

Access to resources Recommend Favorite

Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis

By Field J.   Marshall A.C.J.   J. Hertzog P.   Wells T.N.   Alderuccio F.   Toh B.-H.  

Clinical Immunology, Vol. 109, Iss. 2, 2003-11 ,pp. : 238-247

Elsevier

Access to resources Recommend Favorite